In a previous report, 1) we found a new complex-type N-glycans bearing the Gal1-3GalNAc (T-antigen) unit among the N-glycans obtained from total royal jelly glycoproteins (RJGs), and we proposed a unique Nglycan processing mechanism working in the cephalic portion of the honeybee, indicating the involvement of a new 1-3 galactosyltransferase (1-3GalT) in the Nglycan processing pathway. Furthermore, we confirmed the occurrence of 1-3GalT activity in the microsomal fraction prepared from the cephalic portion of the honeybee.
2) However, at present time, it remains to be determined what royal jelly glycoproteins bear the new complex-type royal jelly N-glycans harboring the T-antigen unit. As a first step to reveal the physiological significance of this complex-type N-glycan, identification of the glycoproteins having the honeybee specific N-glycans and the glycosylation site is prerequisite. Therefore, in this report, we describe the identification of the royal jelly glycoprotein that bears the T-antigen unit and the glycosylation site.
Crude major royal jelly glycoproteins (200 mg) were carboxymethylated 3) and digested with 4 mg of trypsin (TPCK-treated, Sigma, St. Louis, MO, USA) in a 0.1 M ammonium bicarbonate solution (20 ml) at 37 C overnight. The reaction mixture was diluted with water (50 ml) and concentrated with a rotary evaporator. This step was repeated 3 times to remove the volatile salt.
The resulting concentrate was lyophilized, and the lyophilizate was dissolved in 10 ml of the binding solvent (1-butanol/ethanol/water ¼ 4/1/1). After centrifugation (12;000 g, 15 min), the resulting supernatant was added to Sepharose CL-4B resin (17 ml) previously equilibrated with the binding solvent, and the mixture was incubated at 4 C overnight. After centrifugation (5;000 g, 10 min), the supernatant was removed and the resin was washed with the binding solvent again to eliminate contaminative non-glycopeptides. This washing step was repeated 3 times. The bound glycopeptides were eluted from Sepharose CL-4B resin with 50% ethanol/water (20 ml). The eluate, containing glycopeptides, was evaporated to dryness, and the glycopeptides obtained were dissolved in a small amount of 0.05% TFA. Each glycopeptide was purified by RP-HPLC using a Shiseido Capcell Pak C18 MG column (10 Â 250 mm, Shiseido, Tokyo, Japan) by a linear gradient of acetonitrile from 0 to 60% in 0.1% TFA at a flow rate of 1.5 ml/min. As shown Fig. 1-1 and -2, many peptides were separated from the total tryptic digest on the chromatogram, but only a few peaks were obtained from the Sepharose-bound fraction, and major three peptidefractions were positive by the phenol-H 2 SO 4 method, 4) suggesting that these peptides were glycosylated. After blotting onto a PVDF membrane, the amino acid sequences of these purified peptides were analyzed by automatic Edman degradation using an Applied Biosystem Model 494. The amino acid sequences of these three peptides were as follows: GESLX for GP-1, QVEIPHDVAVXATTG (major component in peak-2) and VLDSGLVXNTQPMCS (minor component in peak-2) for GP-2, VLDSGLVXNTQPMCS for GP-3, where x was an unidentified amino acid (perhaps a glycosylated Asn residue). As shown in one of the major royal jelly proteins (MRJP1). 5) In the case of GP-3 (minor component of GP-2), the peptide was obtained as a tryptic digest, but amino acid sequence analysis identified that the peptide bond was cleaved between W(136)-V(137) by trypsin, suggesting the occurrence of non-specific cleavage by trace contaminative chymotrypsin-like activity due to the prolonged incubation time. Furthermore, the glycopeptide, V(137)LDSGLVXNTQPMCS(PK), was eluted at different elution positions (GP-2, and -3), suggesting the possibility of a slight difference in N-glycan moiety.
For structural analysis of N-glycans linked to these purified glycopeptides, the N-glycans were liberated by hydrazinolysis (100 C for 10 h), and the resulting hydrazinolyzate was N-acetylated with saturated sodium bicarbonate and acetic anhydride. The liberated Nglycans were tagged with 2-aminopyridine, as described in our previous paper. 6) After gel-filtration with a Sephadex G-10 column (2:8 Â 45 cm) to exclude excess reagents, the resulting pyridylaminated (PA-) derivatives were partially purified by RP-HPLC using a Shiseido Capcell Pak C18 MG column (10 Â 250 mm), as described in our previous paper. 6) As shown in Fig. 3-I , the RP-HPLC profile of the PA-sugar chain fractions from GP-1 was quite different from those from GP-2 and -3, although those from GP-2 and GP-3 were almost the same as each other. The N-glycan fractions indicated by horizontal bars were pooled and further analyzed by SF-HPLC using a Shodex Asahipak NH2P-50 column (4:6 Â 250 mm, Showa Denko, Tokyo, Japan) at a flow rate of 0.7 ml/min. 6) As in the case of the RP-HPLC profiles, the SF-HPLC profile of the PA-sugar chains from GP-1 was different from those of GP-1 and GP-2. As shown in Fig. 3-II-1 , the elution positions of PA-sugar chains a, b, c, d, and e obtained from GP-1 coincided with authentic complex-type Nglycans:
, and Gal 2 GalNAc 2 GlcNAc 2 Man 3 GlcNAc 2 -PA (v). PA-sugar chains d and e were converted to PA-sugar chain c by 1-3 specific galactosidase digestion (Sigma, St. Louis, MO, USA), indicating that these oligosaccharides contained 1-3 galactosyl residues. Some other PA-sugar chains were sensitive to jack bean -hexsosaminidase digestion (Seikagaku Kogyo, Tokyo, Japan), but some PA-sugar chains were not completely converted to Man 3 GlcNAc 2 -PA, indicating the occurrence of hybridtype structures. On the other hand, SF-HPLC profiles of the PA-sugar chains obtained from GP-2 and -3 were the almost the same, and the elution positions of those coincided with the authentic high-mannose type N-glycans (Man 9 {5 GlcNAc 2 -PA) (Fig. 3-II-2, -3) . Furthermore, these PA-sugar chains were converted to Man 5 GlcNAc 2 -PA by 1-2 mannosidase (Seikagaku Kogyo, Tokyo, Japan) and Man 1 GlcNAc 2 -PA by jack bean -mannosidase (Sigma, St. Louis, MO, USA). The detailed structures of these typical high-mannose-type and some complex-type N-glycans are described in our previous reports. 1, 6, 7) In this study, we identified one royal jelly glycoprotein, MRJP 1, carrying unique N-glycans harboring the Amino acid sequences of purified three glycopeptides in Fig. 1-2 are shown with underlining. The deduced amino acid sequence of MRJPG1 was reported in reference 5.
Identification of Royal Jelly Glycoprotein Bearing the T-Antigen Unit
T-antigen (Gal1-3GalNAc) unit, and found that three N-glycosylation sites occurred in MRJP1. Among MRJPs (MRJP-1 to MRJP-5), the glycosylation site (-GESLN(28)KSL-) was found only in MRJP 1, not in other MRJPs, and hence the T-antigen unit-containing N-glycans may be specifically linked to MRJP 1. Although a putative glycosylation site was found upstream of the N-terminal region of MRJP 4, a minor component of MRJPs, the tryptic peptide was not recovered from a proteolytic mixture of crude RJPs, and hence it is obscure whether the putative glycosylation site was really glycosylated. Furthermore, since MRJPs account for a large share of total royal jelly proteins, it is also possible that other minor RJ glycoproteins bearing T-antigen unit-containing Nglycans were not detected in this study.
At this time, the physiological significance or function of the royal jelly specific new N-glycans (or Nglycoprotein bearing the glycan) remains to be elucidated, but it is worthwhile to refer to a previous report 8) indicating that MRJP 1 (designated RJP-3 in the reference) was expressed in a subset of Kenyon cells in the mushroom bodies of the honeybee brain. The mushroom bodies, which are the memory center in the insect brain, are involved in learning and the formation and storage of memories. The mushroom bodies are most evolved in social Hymenoptera. As is well known, the honeybee is a highly social insect and possesses rich channels of communication, indicating that highly sophisticated brain functions must be integrated in the mushroom bodies. On the other hand, it has been revealed that various N-glycans linked to proteins play critical roles in cell-cell communication and tissue construction, and hence it is possible to assume that unique honeybee-brain-specific N-glycans (or N-glycoprotein such as MRJP1) are involved in the construction of brain tissues, the mushroom body. Recently, we identified a unique honeybee 1-3 galactosyltransferase (1-3GalT) gene involved in the biosynthesis of Nglycans bearing the T-antigen unit. A detailed molecular characterization of the 1-3GalT gene will be described elsewhere.
